Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2008;40(4):1095-8.
doi: 10.1007/s11255-008-9431-y. Epub 2008 Jul 26.

Posterior reversible encephalopathy syndrome (PRES) induced by cyclosporine use in a patient with collapsing focal glomeruloesclerosis

Rodrigo Alves de Oliveira  1 , Lílian Magalhães Fechine, Francisco Costa Neto, José Marcílio Nicodemus, Geraldo B Silva Jr, Leila S V Silva
Affiliations
Case Reports

Posterior reversible encephalopathy syndrome (PRES) induced by cyclosporine use in a patient with collapsing focal glomeruloesclerosis

Rodrigo Alves de Oliveira et al. Int Urol Nephrol. 2008.

Abstract

Background: Posterior reversible encephalopathy syndrome (PRES) is characterized by abnormalities in cerebral white matter and neurologic symptoms. It can be caused by immunosuppressive drugs or autoimmune diseases. We describe a case of PRES in a patient with collapsing focal glomeruloesclerosis (collapsing FGS) with complete recovery after withdrawal of cyclosporine (CSA).

Case report: A 27-year-old male presented a corticosteroid-resistant nephrotic syndrome secondary to collapsing FGS corticosteroid. Treatment with CSA was started after a nonresponding course of prednisone. Three weeks later, he developed an abrupt elevation of blood pressure (210/120 mmHg), with headaches, mental confusion, and generalized seizures. Magnetic resonance imaging (MRI) showed lesions suggestive of PRES. CSA was withdrawn, and a new MRI was normal after 2 months.

Conclusions: PRES is a rare syndrome that must be suspected in every patient presenting neurologic symptoms in the course of immunosuppression. It can be induced by CSA and is totally reversible when the drug is rapidly withdrawn.

PubMed Disclaimer

References

    1. Eur J Neurol. 2003 Jul;10(4):461-2 - PubMed
    1. Intern Med. 2008;47(1):43-5 - PubMed
    1. Pediatr Neurol. 1999 Mar;20(3):241-3 - PubMed
    1. N Engl J Med. 1996 Feb 22;334(8):494-500 - PubMed
    1. Lancet. 1987 Apr 25;1(8539):949-51 - PubMed

Publication types

MeSH terms

LinkOut - more resources